Romain Colle Selected Research

Antidepressive Agents (Antidepressants)

10/2023	A complex relation between levels of adult hippocampal neurogenesis and expression of the immature neuron marker doublecortin.
1/2023	Plasma acetyl-l-carnitine and l-carnitine in major depressive episodes: a case-control study before and after treatment.
11/2022	Tobacco use is associated with low peripheral beta-arrestin 1 levels in major depression: A preliminary report.
10/2022	Astroglial Connexins Inactivation Increases Relapse of Depressive-like Phenotype after Antidepressant Withdrawal.
10/2020	The olfactory deficits of depressed patients are restored after remission with venlafaxine treatment.
3/2020	SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients.
1/2020	Lower plasma vascular endothelial growth factor A in major depressive disorder not normalized after antidepressant treatment: A case control study.
1/2020	Human Dermal Fibroblast: A Promising Cellular Model to Study Biological Mechanisms of Major Depression and Antidepressant Drug Response.
10/2019	HOMA-IR increase after antidepressant treatment in depressed patients with the Met allele of the Val66Met BDNF genetic polymorphism.
12/2018	Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: Findings from the METADAP cohort.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Romain Colle Research Topics

Disease

20	Major Depressive Disorder (Major Depressive Disorders) 11/2022 - 10/2014
3	Mental Disorders (Mental Disorder) 11/2022 - 01/2022
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 10/2015
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 01/2017
2	Neuroinflammatory Diseases 10/2023 - 04/2023
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2023 - 01/2023
2	Infections 11/2022 - 01/2016
2	COVID-19 11/2022 - 03/2022
2	Overweight 12/2018 - 12/2018
2	Weight Gain 12/2018 - 12/2018
1	Inflammation (Inflammations) 10/2023
1	Catatonia 10/2023
1	Pulmonary Embolism 08/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2023
1	Anhedonia 04/2023
1	Mood Disorders (Mood Disorder) 01/2023
1	Depressive Disorder (Melancholia) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Occupational Stress 01/2022
1	Fatigue 01/2021
1	Neoplasms (Cancer) 01/2020
1	Hypertriglyceridemia 01/2020
1	Insulin Resistance 10/2019
1	Schizophrenia (Dementia Praecox) 10/2019
1	Mania (Manias) 01/2019
1	Methemoglobinemia 01/2019
1	Hypertension (High Blood Pressure) 12/2018
1	Alcoholism (Alcohol Abuse) 01/2017
1	Disease Progression 01/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Heart Failure 01/2016
1	Non-alcoholic Fatty Liver Disease 01/2016
1	Substance-Related Disorders (Drug Abuse) 01/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Neurobehavioral Manifestations 11/2014

Drug/Important Bio-Agent (IBA)

19	Antidepressive Agents (Antidepressants)IBA 10/2023 - 04/2015
12	3,4-methylenedioxyethamphetamine (MDEA)IBA 10/2020 - 02/2015
6	2- (4- methyl- 2- thiazolylazo)- 5- diethylaminophenolIBA 01/2020 - 10/2015
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2017
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2019 - 04/2015
2	EnzymesIBA 10/2023 - 04/2023
2	4-trifluoromethylsalicylic acid (HTB)IBA 10/2023 - 04/2023
2	Monoamine Oxidase (MAO)IBA 10/2023 - 04/2023
2	Ketamine FDA LinkGeneric 04/2023 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022 - 03/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2018
1	Amantadine (Aman)FDA LinkGeneric 10/2023
1	Oxygen (Dioxygen)IBA 08/2023
1	Clostridium perfringens epsilon-toxinIBA 07/2023
1	acylcarnitineIBA 05/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2023
1	EsketamineIBA 04/2023
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 11/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2022
1	beta-Arrestin 1IBA 11/2022
1	AnticoagulantsIBA 03/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 10/2020
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 10/2020
1	AnionsIBA 03/2020
1	Superoxides (Superoxide)IBA 03/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Dapsone FDA Link 01/2019
1	Indicators and Reagents (Reagents)IBA 12/2018
1	insulin receptor-related receptor (IRR)IBA 12/2018
1	Glucose (Dextrose)FDA LinkGeneric 12/2018
1	Glycogen Synthase (Synthase I)IBA 11/2018
1	PPAR gammaIBA 01/2017
1	Pioglitazone (Actos)FDA Link 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2016
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 04/2015
1	valylvaline (Val-Val)IBA 04/2015
1	VortioxetineIBA 11/2014
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 10/2014

Therapy/Procedure

1	Artificial Respiration (Mechanical Ventilation) 08/2023
1	Therapeutics 03/2022
1	Ambulatory Care (Outpatient Care) 01/2021